Akèy › Lymphome de Hodgkin › New York
Etid klinik pou Lymphome de Hodgkin nan New York
15 etid pou Lymphome de Hodgkin ap chèche patisipan nan sit nan New York.
Vil nan New York
Tèks ofisyèl etid la (Anglè)
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
- Memorial Sloan Kettering Cancer Center @ Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- ak 1 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT03618550Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- Cornell, New York
Ap rekriteFaz 1
Laj 18 a 100 · Tout sèks · Mizajou Sep 15, 2026 · NCT05798897AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Research Site, New York
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT06137144Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT05272384A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
- Roswell Park Cancer Institute, Buffalo
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 28, 2026 · NCT06150664Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
- Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 3
Laj 16 a 69 · Tout sèks · Mizajou Jul 8, 2026 · NCT04685616A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Roswell Park Cancer Institute, Buffalo
- North Shore University Hospital, Lake Sucess
- Cohen Children's Medical Center of New York, New Hyde
- ak 9 plis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT01351545Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Memorial Sloan Kettering Cancer Center, New York
- University of Rochester Medical Center, Rochester
Ap rekriteEtid obsèvasyon
Laj 8 ak plis · Tout sèks · Mizajou May 20, 2026 · NCT06098430Cord Blood Transplantation in Children and Young Adults With Blood Cancer
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Ap rekriteFaz 2
Jiska laj 26 · Tout sèks · Mizajou May 14, 2026 · NCT07566377A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
- Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- ak 1 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT06377566Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma
- New York Medical Center, Valhalla
Ap rekriteFaz 1/2
Laj 12 a 70 · Tout sèks · Mizajou Apr 15, 2026 · NCT04491370Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- ak 1 plis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Fanm · Mizajou Mar 4, 2026 · NCT01788839AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
- New York Medical College, Valhalla
Ap rekriteFaz 2
1 Day – 30 Years · Tout sèks · Mizajou Aug 8, 2025 · NCT04099966Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma
- New York Medical College, Vallhala
Ap rekriteFaz 2
Laj 3 a 39 · Tout sèks · Mizajou Jun 13, 2025 · NCT05253495Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Children's Hospital New York-Presbyterian, New York
- Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 1
Laj 1 a 21 · Tout sèks · Mizajou Dec 6, 2024 · NCT05476770Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.